Antibodies specific for different T15 idiotopes induce neonatal suppression of the T15 idiotype

The response of BALB/c mice to Pneumococcus pneumoniae is dominated by a single idiotype defined by the phosphorylcholine-binding myeloma protein TEPC 15 (T15). Injection of newborn BALB/c mice with antibodies to the T15 idiotype will lead to suppression of this idiotype. Such mice will respond to the antigen Pneumococcus, but with idiotypically different anti-phosphorylcholine antibodies. In an attempt to further characterize the effect of anti-idiotypic antibodies on induction of tolerance, three monoclonal antibodies specific for different T15 idiotopes were used. Although these antibodies belonged to the mouse immunoglobulin classes, IgG1 or IgG2 alpha, and were derived from different mouse strains, in all cases, a long lasting suppression could be induced. The data show that injection of idiotope-specific antibodies will suppress the T15 idiotype, but not necessarily the idiotope itself. The results are discussed in terms of the mechanism which will lead to the suppression of a dominating idiotype in the newborn mouse.

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...